DGI Health

DGI (Digital Genetics Inc.) is a South Korean biotechnology company specializing in AI-driven drug discovery and precision medicine. The company leverages its proprietary digital genetics platform to analyze multi-omics data and identify novel therapeutic targets and drug candidates with high clinical success potential. DGI focuses on developing next-generation therapies for oncology and rare diseases, utilizing advanced machine learning algorithms to optimize lead compounds. By integrating genomic insights with structural biology, the company aims to accelerate the drug development timeline and provide personalized treatment solutions for complex diseases.